Search Results
Jul 14, 2026, 06:00 ET Great Hearts Arizona Class of 2026 Earns $53.8 Million in Merit Scholarships, Achieves Top Academic Results
Graduates Post Exceptional College-Going Rates, Strong STEM Interest, and Standout National Scholar Honors Across Phoenix Metro SchoolsPHOENIX, July 14, 2026 /PRNewswire-HISPANIC PR WIRE/ --
More news about: Great Hearts Arizona
Jul 14, 2026, 06:00 ET La generación 2026 de Great Hearts Arizona gana $53.8 millones en becas al mérito y obtiene los mejores resultados académicos
Los graduados registran tasas excepcionales de acceso a la universidad, un gran interés por las disciplinas STEM y destacados reconocimientos académicos a nivel nacional en todas las escuelas del área metropolitana de PhoenixPHOENIX,
More news about: Great Hearts Arizona
Jul 13, 2026, 15:25 ET NicholsMD Launches The Hair Lab™: A Dedicated Destination for Dermatologist-Led Hair Restoration, Scalp Health, and Hair Removal
physician-grade scalp care, nutritional support, and at-home devices.Hair thinning, excessive shedding, scalp conditions, and unwanted hair can all stem from a variety of factors, including genetics, hormones, aging, inflammation, nutritional deficiencies, and lifestyle. Because no two patients experience
More news about: NicholsMD of Greenwich
Jul 13, 2026, 11:30 ET Bosch announces $225 million direct funding agreement with the U.S. Department of Commerce as part of a $2 billion investment in Roseville, Calif.
2024, the Bosch Community Fund has invested $200,000 in grant awards to schools and nonprofits in support of science, technology, engineering, and math (STEM) education initiatives, impacting nearly 1,500 students and teachers in the Roseville area. These strategic investments by the Bosch Community Fund
More news about: Bosch
Jul 10, 2026, 13:30 ET Nightwing Awards Scholarship to University of California, Berkeley Student
recognize outstanding students like Ailsa, whose academic achievement and commitment to STEM reflect the values at the core of AFCEA's mission. This scholarship helps support and advance the next generation of STEM and national security professionals within the cyber and intelligence communities.Nightwing
More news about: Nightwing Group, LLC
Jul 10, 2026, 08:42 ET TheWell Bioscience Launches RocketCell™ Cell Viability Enhancer to Improve Cell Recovery, Survival, and Expansion Following Passaging, Cryopreservation, and Organoid Harvesting
researchers to generate more reproducible data while reducing time, cost, and experimental variability."Optimized for induced pluripotent stem cells (iPSCs), neural stem cells (NSCs), organoids, primary cells, and other dissociation-sensitive cultures, RocketCell™ Cell Viability Enhancer integrates seamlessly
More news about: TheWell Bioscience
Jul 10, 2026, 06:44 ET केरल से लेकर Ulster University बेलफास्ट तक: एक अंतरराष्ट्रीय छात्र समावेशन की विरासत छोड़ता है
लिए टेक्नोलॉजी का उपयोग करने के लिए एक साथ लाते हुए, अपने पहले और दूसरे वर्ष में डीन की सूची में शामिल रहीं Harsha ने Ulster University की Women in STEM Society की सह-स्थापना और Hack4Health Hackathon तैयार किया था।"मैं अन्य लोगों के लिए एक विरासत छोड़ने वाले काम करना चाहती हूँ, जिसे वे आगे बढ़ा
More news about: Ulster University
Jul 09, 2026, 19:57 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER
of the European Medicines Agency (EMA) of the company's marketing authorization application (MAA) for narsoplimab for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA)." Specifically, the press release disclosed that "[f]ollowing an oral explanation meeting
More news about: Pomerantz LLP
Jul 09, 2026, 13:09 ET Stem Cell Banking Market Surges to USD 28.9 Billion by 2033, Propelled by 12.4% CAGR - Verified Market Reports®
TypePublic Stem Cell BanksPrivate Stem Cell BanksHybrid Stem Cell BanksBy End-UserHospitalsResearch InstitutesBiopharmaceutical CompaniesAcademic InstitutionsStem Cell Banking Market, By Geography
More news about: Verified Market Reports
Jul 09, 2026, 12:30 ET Hydrogels for Medical Application Market to Reach USD 2.93 Billion by 2033, Expanding at 9.2% CAGR Driven by Advanced Wound Care Demand, Controlled Drug Delivery Innovation, and Tissue Engineering Breakthroughs - Verified Market Research
approach tied to a retinal pigment epithelial cell therapy program that also included a strategic collaboration with a pharmaceutical organization for stem-cell derived therapies.Funding rounds across the Hydrogels for Medical Application Industry show consistent participation by entities with clinical,
More news about: Verified Market Research
Jul 09, 2026, 09:05 ET Life Time Opens New Athletic Country Club at Brea Mall® on July 9; Tenth California Location and Fourth in Orange County
a full-service barKids Academy for children ages three months to 11 years, offering daily programming across movement, sports, arts, STEM and enrichment activitiesComplimentary work lounge providing flexible space to work before and after workouts"We're thrilled
More news about: Life Time, Inc.
Jul 09, 2026, 08:37 ET Aureum Therapeutics Announces Successful Prevention of Recurrent Miscarriage using NomiCell™ Stem Cells in Preclinical Studies
particular subsets of patients, provides the rationale for why mesenchymal stem cells theoretically should prevent miscarriages, and concludes with preclinical data demonstrating superiority of NomiCell™ compared to other stem cells in preventing fetal loss."Recurrent miscarriage in many cases
More news about: Aureum Therapeutics
Jul 09, 2026, 08:05 ET FDA Approves ENNUMO™ (pegfilgrastim-pccg), Accord BioPharma's Second Pegfilgrastim Biosimilar to NEULASTA® (pegfilgrastim)
Syndrome).Limitations of Use: ENNUMO is not indicated for the mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation.To report SUSPECTED ADVERSE REACTIONS, contact Accord BioPharma Inc at 1-866-941-7875 or FDA at
More news about: Accord BioPharma
Jul 09, 2026, 08:00 ET Astellas to Spotlight New Research for Geographic Atrophy at ASRS 2026 Annual Meeting
presentation will highlight preliminary Phase 1b results for ASP7317, an investigational retinal cell therapy for advanced GA and one of the first pluripotent stem cell-derived ophthalmic cell therapies to be tested in clinical trials. The presentation will include information on early signals of potential visual
More news about: Astellas Pharma Inc.
Jul 09, 2026, 07:01 ET From Kerala to Ulster University Belfast: International student leaves legacy of inclusion
makes such a difference," she said.A Dean's List student in her first and second years, Harsha co-founded Ulster University's Women in STEM Society and created the Hack4Health Hackathon, bringing students together to use technology to address health challenges."I want to do things
More news about: Ulster University
Jul 09, 2026, 07:00 ET Matricelf Continues Clinical Execution with Patient Enrollment Preparation Following GLP Safety Success and GMP Manufacturing Milestones
patients with complete thoracic spinal cord injury (AIS A, T2–T12). The collected blood samples will be used to generate induced pluripotent stem cells (iPSCs), which are intended to serve as the cellular component of Matricelf's personalized autologous neural implant.The approval enables
More news about: Matricelf Ltd.
Jul 08, 2026, 23:26 ET /C O R R E C T I O N -- EBONY Media Group/
CrusadersEntertainment PowerhousesGeneration NextInfluential CreatorsLeaders in SportsMedia MavensMusic InnovatorsSTEM TrailblazersFinal honorees will be celebrated at the highly anticipated 2026 EBONY Power 100 ceremony in Los Angeles, produced in partnership
More news about: EBONY Media Group
Jul 08, 2026, 12:05 ET Investing in Tomorrow's Leaders: Cypress Creek Energy Awards 45 Scholarships Across 24 Project Communities Nationwide
where Cypress Creek develops and operates solar and battery storage projects, as well as to encourage students to consider careers in energy or other STEM (Science, Technology, Engineering, Math) fields. In 2026, the program was expanded to 33 municipalities, and with this year's awards, brings the total
More news about: Cypress Creek Energy
Jul 08, 2026, 11:54 ET Cell Culture Media Market worth $12.9 billion by 2033: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG
Ovary (CHO) Cell Culture Media, Protein Expression Media, Stem Cell Media, Hybridoma Media, Primary Cell Media, Insect Cell Media, and Others), Application (Cancer Research, Vaccine Development, Regenerative Medicines, Cell-based Therapies, Stem-cell Research, and Others), End-use, and Regional Analysis
More news about: Persistence Market Research Pvt. Ltd.
Jul 08, 2026, 09:38 ET Porton Advanced's UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance
July 8, 2026 /PRNewswire/ -- Recently, Porton Advanced proudly announced that its Umbilical Cord-Derived Mesenchymal Stem Cell (UC-MSCs) Cell Bank for exosome manufacturing has been accepted for filing by the FDA's Center for Biologics Evaluation and Research (CBER), under
More news about: Porton Advanced
Jul 08, 2026, 09:00 ET The Longevity Protein Race Reaches Manufacturing: One Microcap Just Completed A GMP Master Cell Bank For Its Anti-Aging Klotho Therapy
NewcelX (NASDAQ: NCEL) submitted its pre-IND package to the FDA for a stem-cell-derived islet therapy [4], and Vertex (NASDAQ: VRTX) reported that all 12 patients in the Phase 1/2 portion of its stem-cell-derived islet therapy trial restored insulin production, though it has temporarily
More news about: USA News Group
Jul 08, 2026, 09:00 ET Porton Advanced's UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance
July 8, 2026 /PRNewswire/ -- Recently, Porton Advanced proudly announced that its Umbilical Cord-Derived Mesenchymal Stem Cell (UC-MSCs) Cell Bank for exosome manufacturing has been accepted for filing by the FDA's Center for Biologics Evaluation and Research (CBER), under
More news about: Porton Advanced
Jul 08, 2026, 08:00 ET Study Finds NuLiv Science Ingredient, Senactiv®, Supports Stem Cell Activity and Mitochondrial Gains Following Resistance Exercise in Older Women
post-exercise to assess key markers of stem cell activity and muscle regeneration.The study demonstrated that Senactiv® enhanced the body's natural recovery response to exercise. While exercise alone showed limited effect on the muscle's stem cell activity and energy production, adding
More news about: Nuliv Science
Jul 08, 2026, 07:00 ET RoosterBio and Applied StemCell Partner to Advance Scalable iPSC-Based Bioprocess Solutions
Partnership pairs Applied StemCell's induced pluripotent stem cell technology with RoosterBio's engineered media, reagents, and scalable bioprocess systems to accelerate development and manufacturing of advanced therapiesMILPITAS, Calif. and FREDERICK,
More news about: RoosterBio, Inc.
Jul 08, 2026, 07:00 ET BioLineRx and Hemispherian Announce New Preclinical Data Demonstrating Strong Synergistic Effect between GLIX1 and PARP Inhibitor in a Patient-Derived Ovarian Cancer Xenograft Model
developed under a collaboration with Hemispherian AS.The Company's first approved product, APHEXDA® (motixafortide), is indicated in the U.S. for stem cell mobilization for autologous transplantation in multiple myeloma, and is being commercialized by Ayrmid Ltd. (globally, except Asia) and Gloria
More news about: BioLineRx Ltd.; Hemispherian AS